RCM

RA Capital Management Portfolio holdings

AUM $9.44B
1-Year Est. Return 157.3%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+157.3%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$9.44B
AUM Growth
-$323M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
95
New
Increased
Reduced
Closed

Top Buys

1
+$216M
2
+$114M
3
+$106M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$75.5M
5
NUVL icon
Nuvalent
NUVL
+$66.7M

Top Sells

1
+$743M
2
+$623M
3
+$82.6M
4
BLTE
Belite Bio
BLTE
+$69.2M
5
IVVD icon
Invivyd
IVVD
+$42.3M

Sector Composition

1 Healthcare 99.71%
2 Financials 0.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCSC
76
Perceptive Capital Solutions
PCSC
$123M
$8.23M 0.09%
750,000
ACET icon
77
Adicet Bio
ACET
$87M
$8.05M 0.09%
1,182,624
+234,375
NAMSW icon
78
NewAmsterdam Pharma Warrant
NAMSW
$6.68M 0.07%
333,333
CRVS icon
79
Corvus Pharmaceuticals
CRVS
$1.04B
$6.58M 0.07%
+450,000
RANI icon
80
Rani Therapeutics
RANI
$107M
$6.25M 0.07%
8,500,000
EQ icon
81
Equillium
EQ
$183M
$6.19M 0.07%
+3,096,336
HOWL icon
82
Werewolf Therapeutics
HOWL
$21.9M
$5.56M 0.06%
6,681,307
MGNX icon
83
MacroGenics
MGNX
$264M
$5.39M 0.06%
+1,864,176
MPLT
84
MapLight Therapeutics
MPLT
$1.33B
$5.05M 0.05%
+248,294
PTN
85
Palatin Technologies
PTN
$24.9M
$1.22M 0.01%
70,000
MDLN
86
Medline Inc
MDLN
$30.9B
– –
-335,000
QGEN icon
87
Qiagen
QGEN
$7.55B
– –
-43,976
PGNY icon
88
Progyny
PGNY
$2B
– –
-96,628
KIDS icon
89
OrthoPediatrics
KIDS
$441M
– –
-109,959
IVVD icon
90
Invivyd
IVVD
$336M
– –
-17,119,096
HCAT icon
91
Health Catalyst
HCAT
$102M
– –
-793,749
ACLX
92
DELISTED
Arcellx
ACLX
– –
-1,267,156
RNAM
93
DELISTED
Avidity Biosciences
RNAM
– –
-8,641,031
BLTE
94
Belite Bio
BLTE
$5.78B
– –
-432,484
CDTX
95
DELISTED
Cidara Therapeutics
CDTX
– –
-3,365,523
1 2 3
4